Annual D&A
$123.00 K
+$80.00 K+186.05%
31 December 2023
Summary:
Trevi Therapeutics annual depreciation & amortization is currently $123.00 thousand, with the most recent change of +$80.00 thousand (+186.05%) on 31 December 2023. During the last 3 years, it has risen by +$76.00 thousand (+161.70%). TRVI annual D&A is now at all-time high.TRVI Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$36.00 K
-$2000.00-5.26%
30 September 2024
Summary:
Trevi Therapeutics quarterly depreciation & amortization is currently $36.00 thousand, with the most recent change of -$2000.00 (-5.26%) on 30 September 2024. Over the past year, it has increased by +$1000.00 (+2.86%). TRVI quarterly D&A is now -5.26% below its all-time high of $38.00 thousand, reached on 30 June 2024.TRVI Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$144.00 K
+$1000.00+0.70%
30 September 2024
Summary:
Trevi Therapeutics TTM depreciation & amortization is currently $144.00 thousand, with the most recent change of +$1000.00 (+0.70%) on 30 September 2024. Over the past year, it has increased by +$41.00 thousand (+39.81%). TRVI TTM D&A is now at all-time high.TRVI TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRVI Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +186.1% | +2.9% | +39.8% |
| 3 y3 years | +161.7% | +176.9% | +182.3% |
| 5 y5 years | +434.8% | +227.3% | +234.9% |
TRVI Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +186.1% | -5.3% | +350.0% | at high | +260.0% |
| 5 y | 5 years | at high | +434.8% | -5.3% | +350.0% | at high | +269.2% |
| alltime | all time | at high | +2975.0% | -5.3% | +1700.0% | at high | +7100.0% |
Trevi Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $36.00 K(-5.3%) | $144.00 K(+0.7%) |
| June 2024 | - | $38.00 K(+8.6%) | $143.00 K(+2.9%) |
| Mar 2024 | - | $35.00 K(0.0%) | $139.00 K(+13.0%) |
| Dec 2023 | $123.00 K(+186.0%) | $35.00 K(0.0%) | $123.00 K(+19.4%) |
| Sept 2023 | - | $35.00 K(+2.9%) | $103.00 K(+33.8%) |
| June 2023 | - | $34.00 K(+78.9%) | $77.00 K(+51.0%) |
| Mar 2023 | - | $19.00 K(+26.7%) | $51.00 K(+18.6%) |
| Dec 2022 | $43.00 K(-14.0%) | $15.00 K(+66.7%) | $43.00 K(+7.5%) |
| Sept 2022 | - | $9000.00(+12.5%) | $40.00 K(-9.1%) |
| June 2022 | - | $8000.00(-27.3%) | $44.00 K(-8.3%) |
| Mar 2022 | - | $11.00 K(-8.3%) | $48.00 K(-4.0%) |
| Dec 2021 | $50.00 K | $12.00 K(-7.7%) | $50.00 K(-2.0%) |
| Sept 2021 | - | $13.00 K(+8.3%) | $51.00 K(0.0%) |
| June 2021 | - | $12.00 K(-7.7%) | $51.00 K(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $13.00 K(0.0%) | $50.00 K(+6.4%) |
| Dec 2020 | $47.00 K(+20.5%) | $13.00 K(0.0%) | $47.00 K(+9.3%) |
| Sept 2020 | - | $13.00 K(+18.2%) | $43.00 K(+4.9%) |
| June 2020 | - | $11.00 K(+10.0%) | $41.00 K(+2.5%) |
| Mar 2020 | - | $10.00 K(+11.1%) | $40.00 K(+2.6%) |
| Dec 2019 | $39.00 K(+69.6%) | $9000.00(-18.2%) | $39.00 K(-9.3%) |
| Sept 2019 | - | $11.00 K(+10.0%) | $43.00 K(+19.4%) |
| June 2019 | - | $10.00 K(+11.1%) | $36.00 K(+20.0%) |
| Mar 2019 | - | $9000.00(-30.8%) | $30.00 K(+30.4%) |
| Dec 2018 | $23.00 K(+475.0%) | $13.00 K(+225.0%) | $23.00 K(+130.0%) |
| Sept 2018 | - | $4000.00(0.0%) | $10.00 K(+66.7%) |
| June 2018 | - | $4000.00(+100.0%) | $6000.00(+200.0%) |
| Mar 2018 | - | $2000.00 | $2000.00 |
| Dec 2017 | $4000.00 | - | - |
FAQ
- What is Trevi Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Trevi Therapeutics?
- What is Trevi Therapeutics annual D&A year-on-year change?
- What is Trevi Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Trevi Therapeutics?
- What is Trevi Therapeutics quarterly D&A year-on-year change?
- What is Trevi Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Trevi Therapeutics?
- What is Trevi Therapeutics TTM D&A year-on-year change?
What is Trevi Therapeutics annual depreciation & amortization?
The current annual D&A of TRVI is $123.00 K
What is the all time high annual D&A for Trevi Therapeutics?
Trevi Therapeutics all-time high annual depreciation & amortization is $123.00 K
What is Trevi Therapeutics annual D&A year-on-year change?
Over the past year, TRVI annual depreciation & amortization has changed by +$80.00 K (+186.05%)
What is Trevi Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of TRVI is $36.00 K
What is the all time high quarterly D&A for Trevi Therapeutics?
Trevi Therapeutics all-time high quarterly depreciation & amortization is $38.00 K
What is Trevi Therapeutics quarterly D&A year-on-year change?
Over the past year, TRVI quarterly depreciation & amortization has changed by +$1000.00 (+2.86%)
What is Trevi Therapeutics TTM depreciation & amortization?
The current TTM D&A of TRVI is $144.00 K
What is the all time high TTM D&A for Trevi Therapeutics?
Trevi Therapeutics all-time high TTM depreciation & amortization is $144.00 K
What is Trevi Therapeutics TTM D&A year-on-year change?
Over the past year, TRVI TTM depreciation & amortization has changed by +$41.00 K (+39.81%)